Visualizing Smad1/4 signaling response to bone morphogenetic Protein-4 activation by FRET biosensors

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1773, Issue 12, 2007, Pages 1759-1773

  Gromova, Kira V ^a   Friedrich, Mike ^a   Noskov, Andrey ^a   Harms, Gregory S ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Biosensor; BMP; FRET; GFP; Smad

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CYAN FLUORESCENT PROTEIN; HYBRID PROTEIN; SMAD1 PROTEIN; SMAD4 PROTEIN; YELLOW FLUORESCENT PROTEIN;

ANIMAL CELL; ARTICLE; BIOSENSOR; COMPLEX FORMATION; CONTROLLED STUDY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 36549015178     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2007.09.007     Document Type: Article

References (65)

1. Wozney J.M. The bone morphogenetic protein family and osteogenesis. Mol. Reprod. Dev. 32 (1992) 160-167
2. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., Hewick R.M., and Wang E.A. Novel regulators of bone formation: molecular clones and activities. Science 242 (1988) 1528-1534
3. Moren A., Olofsson A., Stenman G., Sahlin P., Kanzaki T., Claesson-Welsh L., ten Dijke P., Miyazono K., and Heldin C.H. Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein. J. Biol. Chem. 269 (1994) 32469-32478
4. Rosenzweig B.L., Imamura T., Okadome T., Cox G.N., Yamashita H., ten Dijke P., Heldin C.H., and Miyazono K. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7632-7636
5. Liu F., Hata A., Baker J.C., Doody J., Carcamo J., Harland R.M., and Massague J. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381 (1996) 620-623
6. Gilboa L., Nohe A., Geissendorfer T., Sebald W., Henis Y.I., and Knaus P. Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol. Biol. Cell 11 (2000) 1023-1035
7. Massague J. TGF-beta signal transduction. Ann. Rev. Biochem. 67 (1998) 753-791
8. Hayashi H., Abdollah S., Qiu Y., Cai J., Xu Y.Y., Grinnell B.W., Richardson M.A., Topper J.N., Gimbrone Jr. M.A., Wrana J.L., and Falb D. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89 (1997) 1165-1173
9. Luo Q., Nieves E., Kzhyshkowska J., and Angeletti R.H. Endogenous transforming growth factor-beta receptor-mediated Smad signaling complexes analyzed by mass spectrometry. Mol. Cell. Proteomics 5 (2006) 1245-1260
10. Macias-Silva M., Abdollah S., Hoodless P.A., Pirone R., Attisano L., and Wrana J.L. MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87 (1996) 1215-1224
11. Zhang Y., Feng X., We R., and Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature 383 (1996) 168-172
12. Qin B.Y., Lam S.S., Correia J.J., and Lin K. Smad3 allostery links TGF-beta receptor kinase activation to transcriptional control. Genes Dev. 16 (2002) 1950-1963
13. Nakao A., Afrakhte M., Moren A., Nakayama T., Christian J.L., Heuchel R., Itoh S., Kawabata M., Heldin N.E., Heldin C.H., and ten Dijke P. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389 (1997) 631-635
14. Imamura T., Takase M., Nishihara A., Oeda E., Hanai J., Kawabata M., and Miyazono K. Smad6 inhibits signalling by the TGF-beta superfamily. Nature 389 (1997) 622-626
15. Heldin C.H., Miyazono K., and ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390 (1997) 465-471
16. Whitman M. Smads and early developmental signaling by the TGFbeta superfamily. Genes Dev. 12 (1998) 2445-2462
17. Xu L., Alarcon C., Col S., and Massague J. Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import. J. Biol. Chem. 278 (2003) 42569-42577
18. Miyazono K., ten Dijke P., and Heldin C.H. TGF-beta signaling by Smad proteins. Adv. Immunol. 75 (2000) 115-157
19. Abdollah S., Macias-Silva M., Tsukazaki T., Hayashi H., Attisano L., and Wrana J.L. TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem. 272 (1997) 27678-27685
20. Tsuneizumi K., Nakayama T., Kamoshida Y., Kornberg T.B., Christian J.L., and Tabata T. Daughters against dpp modulates dpp organizing activity in Drosophila wing development. Nature 389 (1997) 627-631
21. Lo R.S., Chen Y.G., Shi Y., Pavletich N.P., and Massague J. The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-beta receptors. EMBO J. 17 (1998) 996-1005
22. Feng X.H., and Derynck R. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity. EMBO J. 16 (1997) 3912-3923
23. Derynck R., and Feng X.H. TGF-beta receptor signaling. Biochim. Biophys. Acta 1333 (1997) F105-F150
24. Persson U., Izumi H., Souchelnytskyi S., Itoh S., Grimsby S., Engstrom U., Heldin C.H., Funa K., and ten Dijke P. The L45 loop in type I receptors for TGF-beta family members is a critical determinant in specifying Smad isoform activation. FEBS Lett. 434 (1998) 83-87
25. Tsukazaki T., Chiang T.A., Davison A.F., Attisano L., and Wrana J.L. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 95 (1998) 779-791
26. Shi Y., and Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 (2003) 685-700
27. Zhang Y., Musci T., and Derynck R. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function. Curr. Biol. 7 (1997) 270-276
28. Baker J.C., and Harland R.M. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev. 10 (1996) 1880-1889
29. Lagna G., Hata A., Hemmati-Brivanlou A., and Massague J. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature 383 (1996) 832-836
30. Reguly T., and Wrana J.L. In or out? The dynamics of Smad nucleocytoplasmic shuttling. Trends Cell Biol. 13 (2003) 216-220
31. Gorlich D., and Kutay U. Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell Dev. Biol. 15 (1999) 607-660
32. Gerace L. Nuclear export signals and the fast track to the cytoplasm. Cell 82 (1995) 341-344
33. Yoshida M., Kudo N., and Horinouchi S. Leptomycin: a specific inhibitor of protein nuclear export. Tanpakushitsu Kakusan Koso 44 (1999) 1379-1388
34. Xiao Z., Watson N., Rodriguez C., and Lodish H.F. Nucleocytoplasmic shuttling of Smad1 conferred by its nuclear localization and nuclear export signals. J. Biol. Chem. 276 (2001) 39404-39410
35. Inman G.J., Nicolas F.J., and Hill C.S. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. Mol. Cell 10 (2002) 283-294
36. Xu J., Oakley J., and McGee E.A. Stage-specific expression of Smad2 and Smad3 during folliculogenesis. Biol. Reprod. 66 (2002) 1571-1578
37. Pierreux C.E., Nicolas F.J., and Hill C.S. Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus. Mol. Cell. Biol. 20 (2000) 9041-9054
38. Watanabe M., Masuyama N., Fukuda M., and Nishida E. Regulation of intracellular dynamics of Smad4 by its leucine-rich nuclear export signal. EMBO Rep. 1 (2000) 176-182
39. Schmierer B., and Hill C.S. Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor beta-dependent nuclear accumulation of Smads. Mol. Cell. Biol. 25 (2005) 9845-9858
40. Nicolas F.J., De Bosscher K., Schmierer B., and Hill C.S. Analysis of Smad nucleocytoplasmic shuttling in living cells. J. Cell Sci. 117 (2004) 4113-4125
41. Parsons M., Vojnovic B., and Ameer-Beg S. Imaging protein-protein interactions in cell motility using fluorescence resonance energy transfer (FRET). Biochem. Soc. Trans. 32 (2004) 431-433
42. Pollok B.A., and Heim R. Using GFP in FRET-based applications. Trends Cell Biol. 9 (1999) 57-60
43. Sekar R.B., and Periasamy A. Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations. J. Cell Biol. 160 (2003) 629-633
44. Lohse M.J., Vilardaga J.P., and Bunemann M. Molecular mechanisms of receptor activation: real-time analysis by fluorescence resonance energy transfer. Auton. Autacoid. Pharmacol. 23 (2003) 231-233
45. Gordon G.W., Berry G., Liang X.H., Levine B., and Herman B. Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy. Biophys. J. 74 (1998) 2702-2713
46. Kremers G.J., Goedhart J., van Munster E.B., and Gadella Jr. T.W. Cyan and yellow super fluorescent proteins with improved brightness, protein folding, and FRET Forster radius. Biochemistry 45 (2006) 6570-6580
47. Wu J.W., Hu M., Chai J., Seoane J., Huse M., Li C., Rigotti D.J., Kyin S., Muir T.W., Fairman R., Massague J., and Shi Y. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling. Mol. Cell. 8 (2001) 1277-1289
48. Qin B.Y., Chacko B.M., Lam S.S., de Caestecker M.P., Correia J.J., and Lin K. Structural basis of Smad1 activation by receptor kinase phosphorylation. Mol. Cell. 8 (2001) 1303-1312
49. Fornerod M., Ohno M., Yoshida M., and Mattaj I.W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90 (1997) 1051-1060
50. Jonk L.J., Itoh S., Heldin C.H., ten Dijke P., and Kruijer W. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J. Biol. Chem. 273 (1998) 21145-21152
51. Berney C., and Danuser G. FRET or no FRET: a quantitative comparison. Biophys. J. 84 (2003) 3992-4010
52. Duncan R.R. Fluorescence lifetime imaging microscopy (FLIM) to quantify protein-protein interactions inside cells. Biochem. Soc. Trans. 34 (2006) 679-682
53. Duncan R.R., Bergmann A., Cousin M.A., Apps D.K., and Shipston M.J. Multi-dimensional time-correlated single photon counting (TCSPC) fluorescence lifetime imaging microscopy (FLIM) to detect FRET in cells. J. Microsc. 215 (2004) 1-12
54. Tramier M., Zahid M., Mevel J.C., Masse M.J., and Coppey-Moisan M. Sensitivity of CFP/YFP and GFP/mCherry pairs to donor photobleaching on FRET determination by fluorescence lifetime imaging microscopy in living cells. Microsc. Res. Tech. 69 (2006) 933-939
55. Nohe A., Keating E., Knaus P., and Petersen N.O. Signal transduction of bone morphogenetic protein receptors. Cell. Signal. 16 (2004) 291-299
56. Nohe A., Hassel S., Ehrlich M., Neubauer F., Sebald W., Henis Y.I., and Knaus P. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J. Biol. Chem. 277 (2002) 5330-5338
57. Itoh S., and ten Dijke P. Negative regulation of TGF-beta receptor/Smad signal transduction. Curr. Opin. Cell Biol. 19 (2007) 176-184
58. Hartung A., Bitton-Worms K., Rechtman M.M., Wenzel V., Boergermann J.H., Hassel S., Henis Y.I., and Knaus P. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol. Cell. Biol. 26 (2006) 7791-7805
59. Hill C.S. The Smads. Int. J. Biochem. Cell Biol. 31 (1999) 1249-1254
60. Hata A., Lo R.S., Wotton D., Lagna G., and Massague J. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature 388 (1997) 82-87
61. Peterson R.S., Andhare R.A., Rousche K.T., Knudson W., Wang W., Grossfield J.B., Thomas R.O., Hollingsworth R.E., and Knudson C.B. CD44 modulates Smad1 activation in the BMP-7 signaling pathway. J. Cell Biol. 166 (2004) 1081-1091
62. Chen H.B., Shen J., Ip Y.T., and Xu L. Identification of phosphatases for Smad in the BMP/DPP pathway. Genes Dev. 20 (2006) 648-653
63. Bierie B., and Moses H.L. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat. Rev., Cancer 6 (2006) 506-520
64. Jakowlew S.B. Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev. 25 (2006) 435-457
65. Harradine K.A., and Akhurst R.J. Mutations of TGFbeta signaling molecules in human disease. Ann. Med. 38 (2006) 403-414